A recent decision by a US federal appeals court has reinstated a rule requiring the abortion drug mifepristone to be obtained in person, causing confusion and concern among patients and providers. Carafem, an abortion provider, reported a surge in calls from worried patients. In response, Carafem and some Planned Parenthood clinics have shifted to using misoprostol alone, a slightly less effective but still safe alternative. The Supreme Court has temporarily paused the ruling, allowing mifepristone to be accessed via telehealth until May 11. This situation highlights the ongoing battle over access to reproductive health services, especially after the overturning of Roe v. Wade. The availability of medication abortion through telehealth has become crucial, particularly in states with strict abortion laws.
QUESTION: How might changes in access to medication abortion impact individuals and communities in areas with restrictive abortion laws?
Telehealth Abortion Is Still Possible Without Mifepristone
